Details of the Drug Reposition

General Information of This Drug (ID: DMDRYZK)

Drug Name
Anti-CD19 CAR-T cells   DMDRYZK
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Follicular lymphoma DISVEUR6 2A80 Phase 1/2 [1]
Diffuse large B-cell lymphoma DISSACK3 2A81 Phase 1/2 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 1/2 [1]
Mantle cell lymphoma DISFREOV 2A85.5 Phase 1/2 [1]
Acute lymphocytic leukaemia DISPX75S 2B33.3 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02851589) Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma